Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas.

Braeuning A, Ittrich C, Köhle C, Buchmann A, Schwarz M.

Drug Metab Dispos. 2007 Apr;35(4):503-7. Epub 2007 Jan 12.

2.

Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.

Braeuning A, Menzel M, Kleinschnitz EM, Harada N, Tamai Y, Köhle C, Buchmann A, Schwarz M.

FEBS J. 2007 Sep;274(18):4766-77. Epub 2007 Aug 14.

3.

Zonation of heme synthesis enzymes in mouse liver and their regulation by β-catenin and Ha-ras.

Braeuning A, Schwarz M.

Biol Chem. 2010 Nov;391(11):1305-13. doi: 10.1515/BC.2010.115.

PMID:
20707599
4.

Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.

Giera S, Braeuning A, Köhle C, Bursch W, Metzger U, Buchmann A, Schwarz M.

Toxicol Sci. 2010 May;115(1):22-33. doi: 10.1093/toxsci/kfq033. Epub 2010 Jan 30.

PMID:
20118494
5.

Genotype-phenotype relationships in hepatocellular tumors from mice and man.

Stahl S, Ittrich C, Marx-Stoelting P, Köhle C, Altug-Teber O, Riess O, Bonin M, Jobst J, Kaiser S, Buchmann A, Schwarz M.

Hepatology. 2005 Aug;42(2):353-61.

PMID:
15965925
6.

Zonal gene expression in murine liver: lessons from tumors.

Hailfinger S, Jaworski M, Braeuning A, Buchmann A, Schwarz M.

Hepatology. 2006 Mar;43(3):407-14.

PMID:
16496347
7.

Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.

Braeuning A, Sanna R, Huelsken J, Schwarz M.

Drug Metab Dispos. 2009 May;37(5):1138-45. doi: 10.1124/dmd.108.026179. Epub 2009 Feb 23.

8.

Regulation of cytochrome P450 expression by Ras- and beta-catenin-dependent signaling.

Braeuning A.

Curr Drug Metab. 2009 Feb;10(2):138-58. Review.

PMID:
19275549
9.

Differential gene expression in periportal and perivenous mouse hepatocytes.

Braeuning A, Ittrich C, Köhle C, Hailfinger S, Bonin M, Buchmann A, Schwarz M.

FEBS J. 2006 Nov;273(22):5051-61. Epub 2006 Oct 20.

10.

A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.

Loeppen S, Koehle C, Buchmann A, Schwarz M.

Carcinogenesis. 2005 Jan;26(1):239-48. Epub 2004 Oct 7.

PMID:
15471898
11.

Target genes of the WNT/beta-catenin pathway in Wilms tumors.

Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M.

Genes Chromosomes Cancer. 2006 Jun;45(6):565-74.

PMID:
16575872
12.

The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.

Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J.

J Hepatol. 2008 Jul;49(1):61-71. doi: 10.1016/j.jhep.2008.03.013. Epub 2008 Apr 18.

13.

p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.

Kalkuhl A, Troppmair J, Buchmann A, Stinchcombe S, Buenemann CL, Rapp UR, Kaestner K, Schwarz M.

Hepatology. 1998 Apr;27(4):1081-8.

PMID:
9537449
14.

Comparative transcriptome and proteome analysis of Ha-ras and B-raf mutated mouse liver tumors.

Rignall B, Ittrich C, Krause E, Appel KE, Buchmann A, Schwarz M.

J Proteome Res. 2009 Aug;8(8):3987-94. doi: 10.1021/pr9002933.

PMID:
19476384
15.

Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice.

Braeuning A, Singh Y, Rignall B, Buchmann A, Hammad S, Othman A, von Recklinghausen I, Godoy P, Hoehme S, Drasdo D, Hengstler JG, Schwarz M.

Histochem Cell Biol. 2010 Nov;134(5):469-81. doi: 10.1007/s00418-010-0747-1. Epub 2010 Oct 1.

PMID:
20886225
16.

Ha-ras and β-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors.

Unterberger EB, Eichner J, Wrzodek C, Lempiäinen H, Luisier R, Terranova R, Metzger U, Plummer S, Knorpp T, Braeuning A, Moggs J, Templin MF, Honndorf V, Piotto M, Zell A, Schwarz M.

Int J Cancer. 2014 Oct 1;135(7):1574-85. doi: 10.1002/ijc.28798. Epub 2014 Mar 3.

17.

Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors.

Vorce RL, Goodman JI.

Toxicol Appl Pharmacol. 1989 Sep 15;100(3):398-410.

PMID:
2551075
18.

[Role of Wnt/beta-catenin signaling transduction pathway in rat hepatocarcinogenesis].

Wang QM, Li X, Jia LQ, Yang KM, Zhou HY, Yang HJ.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jul;22(4):454-7. Chinese.

PMID:
16806007
19.

Rex3 (reduced in expression 3) as a new tumor marker in mouse hepatocarcinogenesis.

Braeuning A, Jaworski M, Schwarz M, Köhle C.

Toxicology. 2006 Oct 3;227(1-2):127-35. Epub 2006 Aug 3.

PMID:
16959394
20.

Hepatomas with activating Ctnnb1 mutations in 'Ctnnb1-deficient' livers: a tricky aspect of a conditional knockout mouse model.

Sekine S, Ogawa R, Kanai Y.

Carcinogenesis. 2011 Apr;32(4):622-8. doi: 10.1093/carcin/bgr002. Epub 2011 Jan 7.

PMID:
21216847

Supplemental Content

Support Center